Diabetes News and Research

Latest Diabetes News and Research

Scientists identify new genetic variations that are associated with type 2 diabetes

Scientists have identified a genetic variation in people with type 2 diabetes that affects how the body's muscle cells respond to the hormone insulin, in a new study published today in Nature Genetics.

7 Sep 2009

PPA bus tour raises awareness of patient assistance programs

The "Help is Here Express" bus tour will be stopping in Kentucky throughout the week of September 8 - 11 at various cities in order to help uninsured and financially-struggling Kentuckians access information on programs that provide prescription medicines for free or nearly free.

5 Sep 2009

Sponsor-A-Scientist program launched

The Sbarro Health Research Organization, a nonprofit center for cancer, cardiovascular and diabetes research located at Temple University in Philadelphia and the University of Siena, Italy, has launched Sponsor-A-Scientist program.

5 Sep 2009

New protein fragments identified for anthrax vaccine development

Researchers at Albert Einstein College of Medicine of Yeshiva University have identified two small protein fragments that could be developed into an anthrax vaccine that may cause fewer side effects than the current vaccine.

4 Sep 2009

Novel SLE Responder Index as the primary endpoint in two Phase 3 clinical trials

Human Genome Sciences, Inc. today announced publication by the journal Arthritis Care & Research of an article describing the development and use of a novel evidence-based systemic lupus erythematosus (SLE) Responder Index selected as the primary endpoint of two pivotal Phase 3 clinical trials of BENLYSTA (belimumab) in serologically active patients with SLE.

4 Sep 2009

Takeda receives FDA response regarding NDA for fixed-dose combination of alogliptin and ACTOS

Takeda Pharmaceutical Company Limited ("Takeda") today announced that its wholly owned subsidiary, Takeda Global Research & Development Center, Inc. (U.S.), received on September 2 (U.S. TIME), a complete response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for the fixed-dose combination (FDC) of alogliptin and ACTOS(R) (pioglitazone HCl).

4 Sep 2009

Defective chemical bond in biological tissue may be the reason for diseases, say researchers

Researchers at Vanderbilt University Medical Center led by Billy Hudson, Ph.D., have discovered a new chemical bond in biological tissue, a fundamental discovery that helps explain evolutionary adaptation in the animal kingdom and may shed light on human disease.

4 Sep 2009

OSI Pharmaceuticals initiates two clinical trials with OSI-906 oral insulin-like growth factor-1 receptor inhibitor

OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) announced today the initiation of two clinical trials with OSI-906, the Company’s potential first-in-class, oral insulin-like growth factor-1 receptor (IGF-1R) inhibitor. The first study is a Phase III, multi-center study that will evaluate the use of OSI-906 for patients with locally advanced or metastatic adrenocortical carcinoma (ACC).

4 Sep 2009

South Dakota Biotech Association to present the 4th Annual South Dakota Biotechnology Summit

Investing in Biotechnology for Life, Food and Energy,” is the theme for the 4th Annual South Dakota Biotechnology Summit and Annual Meeting on Thursday, September 17, 2009. This annual event is presented by the South Dakota Biotech Association and will be held at the Ramkota Hotel, Rushmore Room in Sioux Falls, SD.

4 Sep 2009

Americans' health perceptions contradict national statistics

We think we’re healthier than we actually are, suggests a new survey from market research leader Mintel. Surveying Americans about their health, Mintel found people’s perceptions strongly contradict national statistics about obesity, illness and wellness.

4 Sep 2009

AgaMatrix launches Kroger Blood Glucose Monitoring Systems

AgaMatrix, Inc., the makers of the WaveSense(TM) line of blood glucose monitoring products, announced today the launch of the Kroger(R) Blood Glucose Monitoring System (BGM). The Kroger BGM is found exclusively at almost 2,000 Kroger and Kroger-brand stores, including Dillons, Fry's, King Soopers, Fred Meyer, Smith's and Ralphs.

4 Sep 2009

New treatment for vaso-occlusive crisis in sickle cell patients

GlycoMimetics, Inc. (GMI), a clinical-stage biotechnology company that is developing a new class of glycobiology-based therapies for a broad range of indications, today announced that a pilot study of the company’s lead candidate, GMI-1070, is underway in sickle cell patients. The first patients in this pilot study were treated at Children’s Hospital & Research Center Oakland in California.

4 Sep 2009

Type 2 diabetic people not consuming healthy diets

People with type 2 diabetes are not consuming sufficiently healthy diets and could benefit from ongoing nutritional education and counseling, according to a new study by researchers at Wake Forest University School of Medicine and colleagues.

4 Sep 2009

H1N1 vaccine to cost countries $2.50 - $20 per dose

The H1N1 (swine) flu vaccine will cost countries between $2.50 and $20 per dose, based on their ability to pay, according to the director of the Initiative for Vaccine Research at the WHO, Marie-Paule Kieny, Agence France-Presse/Khaleej Times reports. During an interview published in the September issue of the WHO Bulletin, Kieny "also warned that there would not be enough vaccines for the world's population and that people should not rely entirely on the vaccine," the news service writes (9/2).

3 Sep 2009

Reliable and relevant information needed to rein in the costs of federal health-care programs, says study

For economists and policy-makers to understand the true value of the costs and savings of preventive health programs for chronic disease, the Congressional Budget Office (CBO) should incorporate long-term clinical outcomes data and look beyond the 10-year window when making cost estimates, says a team of University of Chicago researchers in today's issue of Health Affairs.

3 Sep 2009

Medtronic's COPE-HCV clinical study commences

Medtronic, Inc., today reported the initiation and first enrollments of patients in COPE-HCV (COntinuous Interferon Delivery via the Medtronic Paradigm Pump Infusion System Clinical Evaluation for Chronic HCV), the company’s first-ever clinical study using an external pump infusion system to treat patients with the hepatitis C virus (HCV).

3 Sep 2009

Low HDL-cholesterol and high triglycerides linked to increased risk of CHD

Low levels of high-density lipoprotein cholesterol (HDL-C) and raised triglycerides, affecting millions of patients worldwide, are strongly linked to significantly increased risk of coronary heart disease (CHD) even in patients who achieve or surpass current low density lipoprotein cholesterol (LDL-C) targets.

3 Sep 2009

Health Information Resource Center recognizes SHPS, presents nine awards

SHPS, a leading provider of health improvement and health benefits solutions, received nine awards for its healthcare communications in the 2009 National Health Information Awards(SM) program.

3 Sep 2009

Green to Grow calls for support of the California Toxics-Free Babies and Toddlers Act

Green to Grow (www.greentogrow.com), a leading Los Angeles-based manufacturer of BPA-free baby bottles that provide a safe alternative to polycarbonate products containing Bisphenol A (BPA) - a chemical currently banned in Canada, Minnesota, Connecticut and under scrutiny in several European nations - is urging the public and California Assembly members to support the Toxics-Free Babies and Toddlers Act (SB 797).

3 Sep 2009

FDA extends review period for Endo Pharmaceuticals' testosterone undecanoate

Endo Pharmaceuticals announced today that it has been informed by the U.S. Food and Drug Administration (FDA) that the agency has extended its review period for its long-acting testosterone undecanoate injection for men diagnosed with hypogonadism, from Sept. 2, 2009 to Dec. 2, 2009.

3 Sep 2009

Diabetes News and Research

Latest Diabetes News and Research

Scientists identify new genetic variations that are associated with type 2 diabetes

PPA bus tour raises awareness of patient assistance programs

Sponsor-A-Scientist program launched

New protein fragments identified for anthrax vaccine development

Novel SLE Responder Index as the primary endpoint in two Phase 3 clinical trials

Takeda receives FDA response regarding NDA for fixed-dose combination of alogliptin and ACTOS

Defective chemical bond in biological tissue may be the reason for diseases, say researchers

OSI Pharmaceuticals initiates two clinical trials with OSI-906 oral insulin-like growth factor-1 receptor inhibitor

South Dakota Biotech Association to present the 4th Annual South Dakota Biotechnology Summit

Americans' health perceptions contradict national statistics

AgaMatrix launches Kroger Blood Glucose Monitoring Systems

New treatment for vaso-occlusive crisis in sickle cell patients

Type 2 diabetic people not consuming healthy diets

H1N1 vaccine to cost countries $2.50 - $20 per dose

Reliable and relevant information needed to rein in the costs of federal health-care programs, says study

Medtronic's COPE-HCV clinical study commences

Low HDL-cholesterol and high triglycerides linked to increased risk of CHD

Health Information Resource Center recognizes SHPS, presents nine awards

Green to Grow calls for support of the California Toxics-Free Babies and Toddlers Act

FDA extends review period for Endo Pharmaceuticals' testosterone undecanoate

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Diabetes News and Research

Latest Diabetes News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in